Literature DB >> 26056286

Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.

Manabu Fuchikami1, Alexandra Thomas1, Rongjian Liu1, Eric S Wohleb1, Benjamin B Land1, Ralph J DiLeone1, George K Aghajanian1, Ronald S Duman2.   

Abstract

Ketamine produces rapid and sustained antidepressant actions in depressed patients, but the precise cellular mechanisms underlying these effects have not been identified. Here we determined if modulation of neuronal activity in the infralimbic prefrontal cortex (IL-PFC) underlies the antidepressant and anxiolytic actions of ketamine. We found that neuronal inactivation of the IL-PFC completely blocked the antidepressant and anxiolytic effects of systemic ketamine in rodent models and that ketamine microinfusion into IL-PFC reproduced these behavioral actions of systemic ketamine. We also found that optogenetic stimulation of the IL-PFC produced rapid and long-lasting antidepressant and anxiolytic effects and that these effects are associated with increased number and function of spine synapses of layer V pyramidal neurons. The results demonstrate that ketamine infusions or optogenetic stimulation of IL-PFC are sufficient to produce long-lasting antidepressant behavioral and synaptic responses similar to the effects of systemic ketamine administration.

Entities:  

Keywords:  antidepressant; glutamate; neural depolarization; prefrontal cortex; synapse

Mesh:

Substances:

Year:  2015        PMID: 26056286      PMCID: PMC4491758          DOI: 10.1073/pnas.1414728112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat.

Authors:  David A Slattery; Inga D Neumann; John F Cryan
Journal:  J Psychopharmacol       Date:  2010-06-08       Impact factor: 4.153

Review 2.  Homeostatic plasticity in the developing nervous system.

Authors:  Gina G Turrigiano; Sacha B Nelson
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

3.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

Review 4.  Ketamine as a novel antidepressant: from synapse to behavior.

Authors:  J W Murrough
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

5.  Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear.

Authors:  Demetrio Sierra-Mercado; Nancy Padilla-Coreano; Gregory J Quirk
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

6.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

Review 7.  How does ketamine elicit a rapid antidepressant response?

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Curr Opin Pharmacol       Date:  2014-11-25       Impact factor: 5.547

Review 8.  Comparing the prefrontal cortex of rats and primates: insights from electrophysiology.

Authors:  Jeremy K Seamans; Christopher C Lapish; Daniel Durstewitz
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans.

Authors:  Jaakko W Långsjö; Elina Salmi; Kaike K Kaisti; Sargo Aalto; Susanna Hinkka; Riku Aantaa; Vesa Oikonen; Tapio Viljanen; Timo Kurki; Martti Silvanto; Harry Scheinin
Journal:  Anesthesiology       Date:  2004-05       Impact factor: 7.892

10.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

View more
  96 in total

1.  VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.

Authors:  Cheng Jiang; Wei-Jye Lin; Benoit Labonté; Carol A Tamminga; Gustavo Turecki; Eric J Nestler; Scott J Russo; Stephen R Salton
Journal:  Neuropsychopharmacology       Date:  2018-11-20       Impact factor: 7.853

Review 2.  Optogenetic investigation of neural mechanisms for alcohol-use disorder.

Authors:  Barbara Juarez; Yutong Liu; Lu Zhang; Ming-Hu Han
Journal:  Alcohol       Date:  2018-06-19       Impact factor: 2.405

3.  GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.

Authors:  Rong-Jian Liu; Catharine Duman; Taro Kato; Brendan Hare; Dora Lopresto; Eunyoung Bang; Jeffery Burgdorf; Joseph Moskal; Jane Taylor; George Aghajanian; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2016-09-16       Impact factor: 7.853

4.  Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Authors:  Gleice Kelli Silva-Cardoso; Manoel Jorge Nobre
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

5.  Ketamine accelerates fear extinction via mTORC1 signaling.

Authors:  Matthew J Girgenti; Sriparna Ghosal; Dora LoPresto; Jane R Taylor; Ronald S Duman
Journal:  Neurobiol Dis       Date:  2016-12-30       Impact factor: 5.996

6.  Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model.

Authors:  Lijia Chang; Kai Zhang; Yaoyu Pu; Youge Qu; Si-Ming Wang; Zhongwei Xiong; Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-29       Impact factor: 5.270

7.  Ketamine increases vmPFC activity: Effects of (R)- and (S)-stereoisomers and (2R,6R)-hydroxynorketamine metabolite.

Authors:  Brendan D Hare; Santosh Pothula; Ralph J DiLeone; Ronald S Duman
Journal:  Neuropharmacology       Date:  2020-01-09       Impact factor: 5.250

Review 8.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

9.  Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.

Authors:  Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-01       Impact factor: 5.270

10.  Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.

Authors:  Satoshi Deyama; Eunyoung Bang; Eric S Wohleb; Xiao-Yuan Li; Taro Kato; Danielle M Gerhard; Sophie Dutheil; Jason M Dwyer; Seth R Taylor; Marina R Picciotto; Ronald S Duman
Journal:  Am J Psychiatry       Date:  2019-01-04       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.